Oculis Pharmaceuticals
Agent39Agent Readiness: 39/100. Below median. Measured by StartupHub.ai. Median 41.Trust82Data Trust: 82/100. Top 25%. Measured by StartupHub.ai. Median 61.Global biopharmaceutical company developing breakthrough treatments for ophthalmic and neuro-ophthalmic conditions.
About
Oculis is a global biopharmaceutical company (Nasdaq: OCS) focused on developing treatments for ophthalmic and neuro-ophthalmic conditions with significant unmet medical needs. The company's proprietary OPTIREACH® formulation technology enables eye drops to effectively reach the back of the eye. Its late-stage clinical pipeline includes Privosegtor (FDA Breakthrough Therapy Designation for optic neuritis), OCS-01 in pivotal studies for diabetic macular edema, and Licaminlimab for dry eye disease.
Similar companies
Biopharmaceutical company developing innovative punctal plug technology for eye disease therapies.
Shares Biopharmaceutical, Ophthalmology
Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.
Shares Biotechnology, Pharmaceuticals
Biopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).
Shares Biotechnology, Pharmaceuticals
Pioneering vision restoration therapies for severe retinal degenerations.
Shares Biotechnology, Pharmaceuticals
Developing Quantum ADCs against the tumor microenvironment for innovative cancer therapies.
Shares Biotechnology, Pharmaceuticals
Developing a next-generation, off-the-shelf, in vivo engineered monocyte immunotherapy platform for solid tumors.
Shares Biotechnology, Pharmaceuticals
Key facts
- Website
- oculis.com
- Headquarters
- Zug, Switzerland
- Founded
- 2017
- Business model
- B2B
Tech stack
Detected on oculis.com, last scanned 21 Oct 2026. Run your own scan
- Analytics
- Google Tag Manager
- CMS / Builders
- WordPress
- CDN
- Cloudflare
- Email provider
- Microsoft 365
- Cookie consent
- Cookiebot
Oculis Pharmaceuticals scores 44. Does yours?
That is its Ahrefs DR: the backlink strength of a domain, on the Ahrefs 0 to 100 scale. Paste your website and you get yours in about a minute.
Frequently asked
Is Oculis Pharmaceuticals trustworthy and reputable?
StartupHub's Data Trust & Reputation score for Oculis Pharmaceuticals is 82 out of 100, a trusted rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.
Public record
SEC filings, insider activity, nonprofit links and pay benchmarks for Oculis Pharmaceuticals
